Kite Pharma | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Industry & Market
No industry information available
Funding Information
No funding information available
Headcount Distribution
No headcount data available
Department Breakdown
No department data available
Keywords & Focus Areas
No keywords available
Overview
Kite Pharma is a biotechnology company based in Santa Monica, California, specializing in cancer immunotherapy. Founded in 2009, it focuses on developing genetically engineered autologous CAR T cell therapies. As a subsidiary of Gilead Sciences since 2017, it has enhanced its capabilities in advancing cell therapy research and commercialization.
The organization is recognized for its pioneering work in immuno-oncology, especially through its flagship products Yescarta® and Tecartus®. Yescarta® is the first FDA-approved CAR T therapy for adult patients with relapsed or refractory large B-cell lymphoma, while Tecartus® serves patients with certain blood cancers, including mantle cell lymphoma. Kite Pharma maintains a robust research pipeline and numerous collaborations to advance cell therapy innovation. With manufacturing facilities located worldwide, including a major site near Amsterdam, the company delivers innovative therapies to adult and pediatric patients with hematologic malignancies.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to
Compare insights from companies similar to , focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxx | $33379 | 30 | Private | - | 2019 | xx |
| xxxxx | $18366 | 74 | Private | - | 2277 | xxxx |
| xxxxxx | $53010 | 83 | Private | - | 1712 | x |
| x | $26498 | 104 | Private | - | 2140 | xxxxxx |
| xxxxxxx | $48758 | 110 | Private | - | 9434 | xxxxxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.